Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Part 3 research outcomes present that giredestrant considerably improved survival with out tumor development in ER-positive superior breast most cancers, based on...
Dr. Christina Cho, a hematologist/oncologist specializing in stem cell transplantation and mobile remedy at Hackensack Meridian Hackensack College Medical Heart’s John Theurer...
